BtLD-01

N/A

Report date: 2023/05/22 10:17:43

Base Information

Drug NameBtLD-01
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitorsAnti-PD-1
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4Programmed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLeidos
China Registration ClassN/A

Develop Information

Active CompaniesLeidos
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A